Source link : https://health365.info/scientific-trial-to-evaluate-protection-efficacy-of-recent-implant-for-male-rigidity-urinary-incontinence/
Urologists at Vanderbilt Well being are enrolling males with rigidity urinary incontinence (SUI) in a medical trial named SOPHIA2 to evaluate the protection and efficacy of the UroActive implant, following an investigational software exemption clearance from the U.S. Meals and Drug Management and the French Nationwide Company for the Protection of Drugs and Well being Merchandise.
SUI, or involuntary urinary leakage, impacts an estimated 40 million American citizens and 90 million Europeans. SUI considerably affects high quality of existence, as it may be debilitating, and frequently ends up in melancholy, low self-esteem and social stigma.
The implant is positioned across the urethral duct and is managed in accordance with the affected person’s task, with out the will for advanced manipulation, intending to supply sufferers conveniently of use and a greater high quality of existence than present choices.
We now have noticed firsthand the shortcomings of present SUI remedy choices for our female and male sufferers. That is why we are so excited to be main the SOPHIA2 trial, as it is appearing promise to supply important enhancements in addressing those problems.”
Melissa Kaufman, MD, PhD, learn about co-principal investigator, the Patricia and Rodes Hart Professor of Urologic Surgical treatment and leader of Reconstructive Urology and Pelvic Well being at Vanderbilt Well being
Kaufman is main the trial within the U.S. in conjunction with Andrew Peterson, MD,…
—-
Author : admin
Publish date : 2026-03-12 04:35:00
Copyright for syndicated content belongs to the linked Source.
—-
1 – 2 – 3 – 4 – 5 – 6 – 7 – 8